BCAX Competitors & Alternatives
Compare Bicara Therapeutics Inc. Common Stock with similar stocks in the same industry
Biotechnology
BCAX
Main Stock$17.07
Tradestie Score
60
Market Cap
$906.29M
Analyst Upside
+108.9%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.19
|
$1.18B | - | 62 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$41.52
|
$1.17B | - | 65 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.66
|
$1.15B | 4.9 | 47 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$12.61
|
$1.14B | - | 55 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$13.17
|
$1.14B | - | 43 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$31.01
|
$1.13B | - | 32 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$3.18
|
$1.12B | - | 47 | Compare |
|
NKTR
Nektar Therapeutics
|
$37.22
|
$1.12B | - | 62 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$252.96
|
$1.12B | - | 65 | Compare |
More BCAX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry